NEEDHAM, Mass.--(BUSINESS WIRE)--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced today that Dr. Una S. Ryan, AVANT’s President and CEO, will be presenting on Monday, February 12th at 2:45 p.m. Eastern Time at the Biotechnology Industry Organization’s BIO CEO & Investor Conference in New York City. This presentation will be webcast live, with replays available for approximately 4 weeks, through the investor information section of AVANT’s website (www.avantimmune.com) or through the conference website run by BIO (www.bio.org).
